<AD>

<WIRE> National Australia Bank (ASX:NAB) Hits Over Three-Month High After Cash Earnings Beat

Shares of National Australia Bank (ASX:NAB) have increased as much as 1.9% to A$28.87, their highest level since May 2.

The bank, currently Australia’s second largest, reported Q3 cash earnings of A$1.90 billion ($1.24 billion), demonstrating growth when compared to A$1.80 billion a year earlier and surpassing a Visible Alpha consensus of A$1.80 billion.

Furthermore, NAB has announced a A$1.5 billion share buyback to progress its common equity tier 1 ratio towards the target range of 11% - 11.5%.

As of end-June, the CET1 ratio was 11.9%, versus 12.2% as of end-March.

For the April-June quarter, the company posted a net interest margin of 1.72%, as opposed to 1.77% as of March 31.

Citi analysts noted a mixed result in a report, highlighting generally soft operating trends but a robust balance sheet.

However, Citi continued to acknowledge better trends and value elsewhere in the banking sector.

As of the last close, NAB stock had dropped approximately 5.8% this year, while a 3.4% rise was reported on the benchmark index.

National Australia Bank offers banking services including personal, business, and private banking, along with insurance and investment services.


<WIRE> Solvar (ASX:SVR) Shares Rise Following Fiscal Year Revenue Increase

Shares in Australia’s Solvar (ASX:SVR) increased up to 6.9% reaching A$1.19 per unit, a high not seen since August 3.

Solvar announced an increase in their fiscal year 2023 revenue by 11.4% to an impressive A$209.3 million, although it did fall short of the estimated A$212.3 million according to Refinitiv data.

The company also declared a final dividend rise of 28.6%, up to A$9.0 cents per share.

Solvar anticipates its loan book to exceed A$1 billion in FY24, and expects bad debt to remain within its target range of 3.5% - 4.5%.

Despite the surge in stock price, Solvar’s market performance this year has seen a decrease of 36.89% when measured from its price at the last close.

Solvar is an Australian company involved in various financial services.


<WIRE> Temple & Webster (ASX:TPW) Absorbs Considerable Loss Following Mediocre Fiscal Year Results

Shares in the furniture retail company Temple & Webster (ASX:TPW) have suffered considerably, marking an intraday drop of as much as 17%, down to A$5.71.

This constitutes the largest drop for the company seen since last February.

In addition to this, the stock has hit its lowest point since July 7.

The reason behind the plummet relates to a concerning fiscal year report.

Our figures show a disappointing A$395.5 million revenue from ordinary activities, which marks a 7.2% regression from the previous year.

The company has also revealed a fiscal year’s profit - before tax - of A$12 million, down by 9.7% from the last fiscal year.

It’s significant to note that more than 3.6 million shares have changed hands recently compared to the 30-day average of around 411,000 shares.

This drop arrives after the stocks had seen a growth of 49.2% this year prior to last closing.

Temple & Webster (ASX:TPW) is an established furniture retailer with a broad customer base.



<WIRE> Uvre (ASX:UVA) Soars following Uranium, Vanadium Discovery at US Project

Uvre shares (ASX:UVA) saw a significant increase, soaring up to 12.5% to A$0.135, marking the highest level since June 7.

The surge came following the company’s confirmation of high-grade uranium and vanadium discovery from surface sampling at its East Canyon project in Utah, United States.

The firm is expected to provide ongoing interpretation of all data, including airborne survey results, over the forthcoming weeks.

This surge in the stock market comes after Uvre’s biggest intraday percentage gain since July 7.

A noticeable shift in investors' activity was observed with over 616,000 shares changing hands, dwarfing the 30-day average of about 136,000 shares.

However, despite this surge, the shares are still down around 7.7% for the year so far.

Uvre is a company engaged in the exploration and development of mineral resources, focusing on uranium and vanadium.


<WIRE> Analysts Maintain Positive Outlook on Carsales.com (ASX:CAR), Raise Price Target

Analysts from Jefferies and Morningstar maintain a positive perspective on Australia’s Carsales.com (ASX:CAR), subsequent to the company’s reports of buoyant results.

The brokerages have raised their price target and fair value estimate for the company to A$25 per share (as per Morningstar) and A$30.19 (as per Jefferies).

Morningstar has noted that the company has decisively transitioned to the next phase of maturity for its North American business.

Additionally, they believe that Carsales.com is less vulnerable to economic fluctuations than the larger vehicle market.

A report from Jefferies highlights that half of company’s earnings currently stem from offshore ventures indicating a faster growth than domestic business.

Out of 16 polled analysts, 11 rate the Carsales.com stock as ‘buy’ or higher, five rate it as ‘hold’.

Their median price target is marked at A$27.45, according to data from Refinitiv.

Despite these promising remarks, the company’s stock has experienced a downturn of 16.3% this year, as of the last closing.

Carsales.com is a digital marketplace, offering automotive, motorcycle and marine classifieds.


<WIRE> Lithium Developer Azure Minerals (ASX:AZS) Shuts Down SQM's Takeover Offer; Shares Surge

Shares of Azure Minerals (ASX:AZS), an Australian lithium developer, have made an impressive leap of up to 12.4% to A$2.63, positioning to record the most significant gain since August 4.

The shares also soared to their highest point since August 8.

Azure Minerals announced that it had turned down a A$901.4 million ($584.11 million) takeover bid from Sociedad Química y Minera de Chile (SQM).

Azure Minerals concluded to dismiss the offer considering the rising potential of its Andover lithium project stationed in Pilbara.

Azure adds that the offer price of A$2.31 per share put forward by the world’s second-largest lithium chemicals manufacturer was below its August 8 intraday peak of A$2.96.

Looking back, the company’s share has ballooned 940% this year up until the last close.

Azure Minerals (ASX:AZS) is a key developer of lithium resources in Australia.


<AD>


<WIRE> Region Re Announces Distributions Per Security Of 15.2 AU CPS

Region Re (ASX:RGN) has announced its per-security distributions of 15.2 AU CPS.

Apart from this, the company stated that it estimates its earnings for FY24 to be FFO per security of 15.6 AU CPS.

Emphasizing that its core strategy stands unaltered, Region Re (ASX:RGN) aims to generate stable, long-lasting cash flows.

The company also vows to keep its attention on building sustainable NOI from their primary business.

Region Re (ASX:RGN) is a company known for driving defensive, resilient cash flows and focusing on sustainable NOI generation from its core business.


<WIRE> Healthco Healthcare and Wellness REIT (ASX:HCW) Announces FY23 DPU of 7.6 AU Cents

Healthco Healthcare and Wellness REIT (ASX:HCW) posted a distribution per unit (DPU) of 7.6 AU cents for fiscal year 23.

Additionally, the company has issued its fiscal year 24 funds from operations (FFO) guidance at 8.0 AU CPU, and has predicted a DPU of 8.0 AU cents for the same period.

The REIT has identified additional assets for sale, which in due course, are expected to bring the company’s balance sheet gearing within the target range of 30-40 percent.

Healthco Healthcare and Wellness REIT is a real estate investment trust that owns, operates, and invests in healthcare and wellness properties.



<WIRE> Charter Hall Retail REIT (ASX:CQR) Announces FY Distribution of 25.80 AU CPU

Charter Hall Retail REIT (ASX:CQR) recently announced its full year distribution, reporting 25.80 AU CPU.

It’s also projected that the operating earnings for fiscal year ‘24 will be approximately 27.4 AU cents per unit.

The company foresees the distribution payout ratio in FY24 to be in the range of 90 to 95% of operating earnings.

Charter Hall Retail REIT is a Real Estate Investment Trust that operates a portfolio of high-quality Australian supermarket anchored convenience retail centres.


<WIRE> Bioxyne Signs Joint Venture with Canxchange (ASX:BXN)

Bioxyne (ASX:BXN) has signed a joint venture with Canxchange.

The partnership aims to launch an AI-powered B2B platform in Australia.

This upcoming platform, which is expected to go live in the fourth quarter of 2023, will target the rapidly expanding medicinal cannabis market in Australia.

Bioxyne is a biotechnological company involved in the development and commercialization of probiotic products.